Gene: GLDC
Official Full Name: glycine decarboxylaseprovided by HGNC
Gene Summary: Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the P protein, which binds to glycine and enables the methylamine group from glycine to be transferred to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH).[provided by RefSeq, Jan 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37642 | GLDC Knockout cell line (HCT 116) | Human | GLDC | 1:2~1:4 | Negative | Online Inquiry |
KO37643 | GLDC Knockout cell line (HEK293) | Human | GLDC | 1:3~1:6 | Negative | Online Inquiry |
KO37644 | GLDC Knockout cell line (A549) | Human | GLDC | 1:3~1:4 | Negative | Online Inquiry |
GLDC Gene Knockout Cell Lines are a cutting-edge biological tool designed to facilitate the study of gene function and the pathways they regulate. These cell lines are characterized by the targeted deletion of the GLDC gene, which encodes the enzyme glycine decarboxylase, pivotal in the glycine cleavage system. By providing specific and reproducible models, these knockout lines enable researchers to examine the consequences of GLDC loss on cellular metabolism and associated physiological processes.
The key function of GLDC Gene Knockout Cell Lines revolves around their ability to mimic conditions of glycine dysregulation, thereby allowing the investigation of its role in metabolic disorders and neurodegenerative diseases. These cell lines maintain the requisite cellular architecture while lacking the GLDC enzyme, which enhances our understanding of metabolic shifts and compensatory pathways in various disease models. Researchers can utilize these cell lines to test experimental therapeutics or evaluate the impact of genetic compensation on cellular health.
Scientifically, GLDC knockout models are invaluable for elucidating mechanisms of diseases such as nonketotic hyperglycinemia, where glycine accumulation can be detrimental. Their application extends into drug discovery and screening, where understanding the metabolic context can lead to the identification of novel therapeutic targets.
When compared to alternatives such as CRISPR/Cas9 generated models, GLDC Gene Knockout Cell Lines offer a quicker and more straightforward solution for immediate application in the laboratory due to their ready-to-use nature and validated characterization. This ease of use provides researchers with a significant advantage in experimental timelines and reproducibility.
For researchers and clinicians aiming to unravel complex metabolic interactions or develop novel treatment strategies, the GLDC Gene Knockout Cell Lines serve as an essential asset. They represent not only the culmination of extensive research but also the commitment of our company as a leader in innovative biological products. Our expertise ensures that these cell lines are rigorously tested and optimized, fostering progress in the field of biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.